Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years
Bielfeld A, Schwarze J, Verpillat P, Lispi M, Fischer R, Hayward B, Chuderland D, D'Hooghe T, Krussel J. Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35–40 years. Reproductive BioMedicine Online 2023, 48: 103725. PMID: 38593745, DOI: 10.1016/j.rbmo.2023.103725.Peer-Reviewed Original ResearchAdvanced maternal ageWomen of advanced maternal ageR-hLHR-hFSHRecombinant human FSHLive birthsClinical pregnancyOvarian stimulationHuman FSHPost hoc analysis of womenRecombinant human LHLive birth rateNormal ovarian reserveNon-interventional studyAssisted reproductive technologyAnalysis of womenPost hoc analysisOvarian reserveMaternal ageEffects of treatmentHuman LHAlone groupPatient groupClinical trialsART treatment